| RS2989924 |
AQP7
|
Health Risk |
risk factor |
OBESITY (BMIQ17), SUSCEPTIBILITY TO |
| RS3007037 |
MGAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
MGAT2-congenital disorder of glycosylation, MGAT2-congenital disorder of glycosylation |
| RS3025968 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS3026397 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Anophthalmia-microphthalmia syndrome, Foveal hypoplasia 1 |
| RS3026906 |
ECE1
|
Health Risk |
Pathogenic |
Hirschsprung disease, cardiac defects |
| RS3032358 |
AR
|
Health Risk |
Pathogenic |
Kennedy disease, Kennedy disease |
| RS3034796 |
CFTR
|
Health Risk |
Pathogenic |
Hereditary pancreatitis, Cystic fibrosis |
| RS3038807 |
RTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS3071247 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS3072277 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS3075570 |
DIAPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome, Autosomal dominant nonsyndromic hearing loss 1 |
| RS3087376 |
FANCI;POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
POLG-related disorder, Progressive sclerosing poliodystrophy |
| RS3087378 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
POLG-related disorder, Progressive sclerosing poliodystrophy |
| RS3087456 |
CIITA
|
Health Risk |
risk factor |
Rheumatoid arthritis, Rheumatoid arthritis |
| RS3087467 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, NTHL1-related disorder |
| RS3087469 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3 |
| RS3088362 |
CCDC122
|
Health Risk |
Uncertain risk allele |
Leprosy, susceptibility to |
| RS3092826 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS3092828 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS3092831 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS3092834 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS3092841 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS3092842 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS3092859 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS3092891 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS3092900 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS3092903 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS3092907 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS3093221 |
CYP4F2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lung cancer, Lung cancer |
| RS3093248 |
F7
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor VII deficiency, Myocardial infarction |
| RS3093266 |
F7
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor VII deficiency, Factor VII deficiency |
| RS3093370 |
IL21R
|
Health Risk |
Conflicting classifications of pathogenicity |
Cryptosporidiosis-chronic cholangitis-liver disease syndrome, Cryptosporidiosis-chronic cholangitis-liver disease syndrome |
| RS3093765 |
LIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
DNA ligase IV deficiency, Multiple myeloma |
| RS311103 |
-
|
Health Risk |
Pathogenic |
XG BLOOD GROUP SYSTEM, Xg(a-) PHENOTYPE |
| RS3120649 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS312262685 |
ZMPSTE24
|
Health Risk |
Pathogenic |
— |
| RS312262686 |
ZMPSTE24
|
Health Risk |
Pathogenic |
Lethal tight skin contracture syndrome, Mandibuloacral dysplasia with type B lipodystrophy |
| RS312262690 |
ANTXR2
|
Health Risk |
Pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS312262693 |
ANTXR2
|
Health Risk |
Pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS312262694 |
DGKE
|
Health Risk |
Likely pathogenic |
Hemolytic uremic syndrome, atypical |
| RS312262696 |
DGKE
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome, Immunoglobulin-mediated membranoproliferative glomerulonephritis |
| RS312262697 |
DGKE
|
Health Risk |
Pathogenic, low penetrance |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS312262698 |
DGKE
|
Health Risk |
Pathogenic, low penetrance |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS312262699 |
DGKE
|
Health Risk |
Pathogenic |
Hemolytic uremic syndrome, atypical |
| RS312262702 |
TRIM37
|
Health Risk |
Pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS312262706 |
TRIM37
|
Health Risk |
Pathogenic/Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS312262709 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS312262711 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262714 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS312262715 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS312262716 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Charcot-Marie-Tooth disease axonal type 2X |
| RS312262717 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262719 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Charcot-Marie-Tooth disease axonal type 2X |
| RS312262720 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS312262721 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262722 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Inborn genetic diseases |
| RS312262723 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS312262725 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS312262726 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS312262727 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS312262728 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262730 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262732 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262734 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262735 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262737 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Charcot-Marie-Tooth disease axonal type 2X |
| RS312262738 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262739 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS312262740 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS312262741 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262742 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262743 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262744 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262745 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS312262747 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS312262748 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS312262749 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS312262750 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262752 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS312262753 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Charcot-Marie-Tooth disease axonal type 2X |
| RS312262755 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Spastic paraplegia |
| RS312262757 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262759 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Inborn genetic diseases |
| RS312262762 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262763 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Inborn genetic diseases |
| RS312262764 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Inborn genetic diseases |
| RS312262765 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262766 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262767 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, SPG11-related disorder |
| RS312262769 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262770 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Inborn genetic diseases |
| RS312262774 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS312262775 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS312262776 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, SPG11-related spastic paraplegia |
| RS312262777 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262778 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262779 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262780 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS312262781 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS312262782 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Inborn genetic diseases |